Evaluation of Intermittent Triple Therapies in Real Life
Recruiting
Observational Study
HIV Infections
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The strategy of intermittent triple therapy for people living with HIV was validated in France following the randomized clinical trial QUATUOR. There is little data in real life, as shown in the meta-analysis of Parienti JJ et al.
Currently this strategy is proposed by some teams in France, but is not recommended internationally.
The research hypothesis is that intermittent treatment is an effec…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* Adult subject (≥ 18 years old)
* Living with HIV monitored at the Trait d'Union/Infectious Diseases department in Strasbourg
* Having benefited from intermittent triple therapy between 01/01/2017 and 31/01/2024
Exclusion criteria:
* Subject (and/or their legal representative…
Contacts